Correlation Between GlaxoSmithKline PLC and Janus Aspen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Janus Aspen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Janus Aspen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Janus Aspen Perkins, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Janus Aspen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Janus Aspen. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Janus Aspen.

Diversification Opportunities for GlaxoSmithKline PLC and Janus Aspen

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Janus is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Janus Aspen Perkins in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janus Aspen Perkins and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Janus Aspen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janus Aspen Perkins has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Janus Aspen go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Janus Aspen

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 4.09 times less return on investment than Janus Aspen. In addition to that, GlaxoSmithKline PLC is 1.58 times more volatile than Janus Aspen Perkins. It trades about 0.02 of its total potential returns per unit of risk. Janus Aspen Perkins is currently generating about 0.11 per unit of volatility. If you would invest  1,527  in Janus Aspen Perkins on August 29, 2024 and sell it today you would earn a total of  487.00  from holding Janus Aspen Perkins or generate 31.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Janus Aspen Perkins

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Janus Aspen Perkins 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Janus Aspen Perkins are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Janus Aspen may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Janus Aspen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Janus Aspen

The main advantage of trading using opposite GlaxoSmithKline PLC and Janus Aspen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Janus Aspen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janus Aspen will offset losses from the drop in Janus Aspen's long position.
The idea behind GlaxoSmithKline PLC ADR and Janus Aspen Perkins pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities